Publication | Open Access

Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma

NanomedicineEngineeringDendritic CellImmunologyTherapeutic VaccineNano-drug DeliveryTumor TargetingBiomedical EngineeringTumor AntigenImmunotherapyMedicineSilicon MicroparticleTumor Microenvironment